These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 16944962)

  • 1. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
    Jaquenoud Sirot E; van der Velden JW; Rentsch K; Eap CB; Baumann P
    Drug Saf; 2006; 29(9):735-68. PubMed ID: 16944962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations for therapeutic monitoring of antidepressants].
    Baumann P; Rougemont M; Corruble E; Hiemke C;
    Rev Med Suisse; 2013 Mar; 9(377):577-86. PubMed ID: 23534245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
    Gervasini G; Benítez J; Carrillo JA
    Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics: the therapeutic drug monitoring of the future?
    Ensom MH; Chang TK; Patel P
    Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
    Stephan PL; Etzensberger M; Jaquenoud Sirot E
    Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
    Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
    Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.
    Hiemke C
    Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous reports and pharmacogenetics: the role of the pharmacovigilance centre.
    van Puijenbroek E; Conemans J; van Grootheest K
    Drug Saf; 2009; 32(4):357-8. PubMed ID: 19388726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
    Anderson GD
    Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.
    Baumann P; Ulrich S; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Hiemke C;
    Dialogues Clin Neurosci; 2005; 7(3):231-47. PubMed ID: 16156382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.
    Spina E; Hiemke C; de Leon J
    Expert Opin Drug Metab Toxicol; 2016; 12(4):407-22. PubMed ID: 26878495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The convergence of therapeutic drug monitoring and pharmacogenetic testing to optimize efavirenz therapy.
    Cabrera Figueroa S; Fernández de Gatta M; Hernández García L; Domínguez-Gil Hurlé A; Bustos Bernal C; Sepúlveda Correa R; García Sánchez MJ
    Ther Drug Monit; 2010 Oct; 32(5):579-85. PubMed ID: 20720517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
    De Bruin ML; van Puijenbroek EP; Bracke M; Hoes AW; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):99-105. PubMed ID: 16329159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.